Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/25803
Title: Awareness of appropriate antibiotic use in primary care for influenza-like illness: Evidence of improvement from UK population-based surveys
Authors: Pouwels, KB
Roope, LSJ
Buchanan, J
Morrell, L
Tonkin-Crine, S
Peters, M
Jones, LF
Castro-Sánchez, E
Crook, DW
Peto, T
Butler, CC
Robotham, JV
Walker, AS
Wordsworth, S
Keywords: antibiotics;antimicrobial resistance;survey
Issue Date: 13-Oct-2020
Publisher: MDPI AG
Citation: Pouwels, K.B. et al. (2020) 'Awareness of appropriate antibiotic use in primary care for influenza-like illness: Evidence of improvement from UK population-based surveys', Antibiotics, 9 (10), 690, pp. 1 - 16. doi: 10.3390/antibiotics9100690.
Abstract: Copyright © 2020 by the authors. Influenza-like illnesses (ILI) account for a significant portion of inappropriate antibiotic use. Patient expectations for antibiotics for ILI are likely to play a substantial role in ‘unnecessary’ antibiotic consumption. This study aimed to investigate trends in awareness of appropriate antibiotic use and antimicrobial resistance (AMR). Three sequential online surveys of independent representative samples of adults in the United Kingdom investigated expectations for, and consumption of, antibiotics for ILI (May/June 2015 (n = 2064); Oct/Nov 2016 (n = 4000); Mar 2017 (n = 4000)). Respondents were asked whether they thought antibiotics were effective for ILI and about their antibiotic use. Proportions and 95% confidence intervals (CI) were calculated for each question and interactions with respondent characteristics were tested using logistic regression. Over the three surveys, the proportion of respondents who believed antibiotics would “definitely/probably” help an ILI fell from 37% (95% CI 35–39%) to 28% (95% CI 26–29%). Those who would “definitely/probably” visit a doctor in this situation fell from 48% (95% CI 46–50%) to 36% (95% CI 34–37%), while those who would request antibiotics during a consultation fell from 39% (95% CI 37–41%) to 30% (95% CI 29–32%). The percentage of respondents who found the information we provided about AMR “new/surprising” fell from 34% (95% CI 32–36%) to 28% (95% CI 26–31%). Awareness improved more among black, Asian and minority ethnic (BAME) than white people, with little other evidence of differences in improvements between subgroups. Whilst a degree of selection bias is unavoidable in online survey samples, the results suggest that awareness of AMR and appropriate antibiotic use has recently significantly improved in the United Kingdom, according to a wide range of indicators.
Description: Supplementary Materials: The following are available online at https://www.mdpi.com/2079-6382/9/10/690/s1, Figure S1: Changes from Survey 1 (red) to Survey 3 (blue) in the percentage of individuals who would go to the GP with ILI by population subgroup; Figure S2. Changes from Survey 1 (red) to Survey 3 (blue) in the percentage of individuals would ask for antibiotics by population subgroup; Figure S3. Changes from Survey 1 (red) to Survey 3 (blue) in the percentage of individuals that have taken antibiotics for ILI in the past 12 months by population subgroup; Figure S4. Changes from Survey 1 (red) to Survey 3 (blue) in the percentage of individuals that would go to GP with a child with ILI by population subgroup; Figure S5. Changes from Survey 1 (red) to Survey 3 (blue) in the percentage of individuals that would ask for antibiotics for a child with ILI by population subgroup; Figure S6. Changes from Survey 1 (red) to Survey 3 (blue) in the percentage of individuals that think antibiotics would help for a child with ILI by population subgroup; Figure S7. Changes from Survey 1 (red) to Survey 3 (blue) in the percentage of individuals for which child has taken an antibiotic for ILI in the past 12 months by population subgroup; Figure S8. Changes from Survey 1 (red) to Survey 3 (blue) in the percentage of individuals for which AMR information was surprising/new by population subgroup.
URI: https://bura.brunel.ac.uk/handle/2438/25803
DOI: https://doi.org/10.3390/antibiotics9100690
Other Identifiers: ORCID iDs: Koen B. Pouwels https://orcid.org/0000-0001-7097-8950; Laurence S. J. Roope https://orcid.org/0000-0001-9098-9331; Liz Morrell https://orcid.org/0000-0001-6382-1795; Sarah Tonkin-Crine https://orcid.org/0000-0003-4470-1151; Leah F. Jones https://orcid.org/0000-0002-0448-3471; Enrique Castro-Sánchez https://orcid.org/0000-0002-3351-9496; Christopher C. Butler https://orcid.org/0000-0002-0102-3453; Julie V. Robotham https://orcid.org/0000-0003-2515-4084.
690
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).711.64 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons